Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis
Study to determine effectiveness and safety of zoledronic acid and whether it has a pharmaco-economic impact in prostate cancer with bone metastasis.
Prostate Cancer With Bone Metastasis
DRUG: zoledronic acid
to assess the effectiveness of Zol in prevention of SREs in stratified groups (hormonal treatment), at 15 months & at end of study
to assess the effectiveness of Zol in improving pain and QoL in prostate cancer patients with bone metastases, V1, V2, V3, V5|to assess the safety of ZOL treatment, V1, V2, V3, V5|to assess resources consumption, V1, V2, V3, V5|to assess BM, V1 et V5
Study to determine effectiveness and safety of zoledronic acid and whether it has a pharmaco-economic impact in prostate cancer with bone metastasis.